Alternative polyadenylation is a determinant of oncogenic Ras function
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Alternative polyadenylation is a determinant of oncogenic Ras function
Authors
Keywords
-
Journal
Science Advances
Volume 7, Issue 51, Pages -
Publisher
American Association for the Advancement of Science (AAAS)
Online
2021-12-18
DOI
10.1126/sciadv.abh0562
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oncogenic mutant RAS signaling activity is rescaled by the ERK/MAPK pathway
- (2020) Taryn E Gillies et al. Molecular Systems Biology
- Nudt21 regulates the alternative polyadenylation of Pak1 and is predictive in the prognosis of glioblastoma patients
- (2019) Yuan Chu et al. ONCOGENE
- PPA1 promotes NSCLC progression via a JNK- and TP53-dependent manner
- (2019) Dehong Luo et al. Oncogenesis
- ABCC1-Exported Sphingosine-1-phosphate, Produced by Sphingosine Kinase 1, Shortens Survival of Mice and Patients with Breast Cancer
- (2018) Akimitsu Yamada et al. MOLECULAR CANCER RESEARCH
- OUP accepted manuscript
- (2018) NUCLEIC ACIDS RESEARCH
- NUDT21 negatively regulates PSMB2 and CXXC5 by alternative polyadenylation and contributes to hepatocellular carcinoma suppression
- (2018) Sheng Tan et al. ONCOGENE
- CFIm25 inhibits hepatocellular carcinoma metastasis by suppressing the p38 and JNK/c-Jun signaling pathways
- (2018) Yunwu Wang et al. Oncotarget
- Widespread intronic polyadenylation inactivates tumour suppressor genes in leukaemia
- (2018) Shih-Han Lee et al. NATURE
- Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes
- (2018) Sebastian Mueller et al. NATURE
- What Are 3′ UTRs Doing?
- (2018) Christine Mayr Cold Spring Harbor Perspectives in Biology
- Group I Paks are essential for epithelial- mesenchymal transition in an Apc-driven model of colorectal cancer
- (2018) H. Y. Chow et al. Nature Communications
- Therapeutic strategies to target RAS-mutant cancers
- (2018) Meagan B. Ryan et al. Nature Reviews Clinical Oncology
- New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
- (2018) Anushka Dongre et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Variation in organ-specific PIK3CA and KRAS mutant levels in normal human tissues correlates with mutation prevalence in corresponding carcinomas
- (2017) Barbara L. Parsons et al. ENVIRONMENTAL AND MOLECULAR MUTAGENESIS
- Cancer-Associated Mutations in Endometriosis without Cancer
- (2017) Michael S. Anglesio et al. NEW ENGLAND JOURNAL OF MEDICINE
- Integrin-β4 identifies cancer stem cell-enriched populations of partially mesenchymal carcinoma cells
- (2017) Brian Bierie et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Silencing NUDT21 Attenuates the Mesenchymal Identity of Glioblastoma Cells via the NF-κB Pathway
- (2017) Jia-Cheng Lou et al. Frontiers in Molecular Neuroscience
- Flexible expressed region analysis for RNA-seq withderfinder
- (2016) Leonardo Collado-Torres et al. NUCLEIC ACIDS RESEARCH
- miR-145 sensitizes breast cancer to doxorubicin by targeting multidrug resistance-associated protein-1
- (2016) Man Gao et al. Oncotarget
- Streamlined Genome Engineering with a Self-Excising Drug Selection Cassette
- (2015) Daniel J. Dickinson et al. GENETICS
- Aneuploidy and chromosomal instability in cancer: a jackpot to chaos
- (2015) Maybelline Giam et al. Cell Division
- Streamlined Genome Engineering with a Self-Excising Drug Selection Cassette
- (2015) Daniel J. Dickinson et al. GENETICS
- Inhibition of multidrug resistance protein 1 (MRP1) improves chemotherapy drug response in primary and recurrent glioblastoma multiforme
- (2015) Amanda Tivnan et al. Frontiers in Neuroscience
- Chemokines in tumor progression and metastasis
- (2015) Purvaba J. Sarvaiya et al. Oncotarget
- Methylation-regulated miR-149 modulates chemoresistance by targeting GlcNAcN-deacetylase/N-sulfotransferase-1 in human breast cancer
- (2014) Dong-Xu He et al. FEBS Journal
- CFIm25 links alternative polyadenylation to glioblastoma tumour suppression
- (2014) Chioniso P. Masamha et al. NATURE
- Sailfish enables alignment-free isoform quantification from RNA-seq reads using lightweight algorithms
- (2014) Rob Patro et al. NATURE BIOTECHNOLOGY
- Drugging the undruggable RAS: Mission Possible?
- (2014) Adrienne D. Cox et al. NATURE REVIEWS DRUG DISCOVERY
- Dynamic analyses of alternative polyadenylation from RNA-seq reveal a 3′-UTR landscape across seven tumour types
- (2014) Zheng Xia et al. Nature Communications
- Ubiquitously transcribed genes use alternative polyadenylation to achieve tissue-specific expression
- (2013) S. Lianoglou et al. GENES & DEVELOPMENT
- The genetic landscape of high-risk neuroblastoma
- (2013) Trevor J Pugh et al. NATURE GENETICS
- Noncanonical control of C. elegans germline apoptosis by the insulin/IGF-1 and Ras/MAPK signaling pathways
- (2012) A J Perrin et al. CELL DEATH AND DIFFERENTIATION
- A quantitative atlas of polyadenylation in five mammals
- (2012) Adnan Derti et al. GENOME RESEARCH
- Detecting differential usage of exons from RNA-seq data
- (2012) S. Anders et al. GENOME RESEARCH
- GENCODE: The reference human genome annotation for The ENCODE Project
- (2012) J. Harrow et al. GENOME RESEARCH
- MondoA is highly overexpressed in acute lymphoblastic leukemia cells and modulates their metabolism, differentiation and survival
- (2012) Caroline M. Wernicke et al. LEUKEMIA RESEARCH
- Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B
- (2012) Yu Sun et al. NATURE MEDICINE
- The deubiquitination enzyme USP46 functions as a tumor suppressor by controlling PHLPP-dependent attenuation of Akt signaling in colon cancer
- (2012) X Li et al. ONCOGENE
- C. elegans VANG-1 Modulates Life Span via Insulin/IGF-1-Like Signaling
- (2012) Sebastian J. Honnen et al. PLoS One
- Modulating the Strength and Threshold of NOTCH Oncogenic Signals by mir-181a-1/b-1
- (2012) Rita Fragoso et al. PLoS Genetics
- E2F mediates enhanced alternative polyadenylation in proliferation
- (2012) Ran Elkon et al. GENOME BIOLOGY
- Paracrine and Autocrine Signals Induce and Maintain Mesenchymal and Stem Cell States in the Breast
- (2011) Christina Scheel et al. CELL
- Phase II, Open-Label, Randomized Trial of the MEK1/2 Inhibitor Selumetinib as Monotherapy versus Temozolomide in Patients with Advanced Melanoma
- (2011) J. M. Kirkwood et al. CLINICAL CANCER RESEARCH
- Mechanisms and Consequences of Alternative Polyadenylation
- (2011) Dafne Campigli Di Giammartino et al. MOLECULAR CELL
- Integrin-mediated function of Rab GTPases in cancer progression
- (2010) Dhatchayini Subramani et al. Molecular Cancer
- DamID in C. elegans reveals longevity-associated targets of DAF-16/FoxO
- (2010) Eugene Schuster et al. Molecular Systems Biology
- Formation, regulation and evolution of Caenorhabditis elegans 3′UTRs
- (2010) Calvin H. Jan et al. NATURE
- Phenotype and Genotype of Pancreatic Cancer Cell Lines
- (2010) Emily L. Deer et al. PANCREAS
- Widespread Shortening of 3′UTRs by Alternative Cleavage and Polyadenylation Activates Oncogenes in Cancer Cells
- (2009) Christine Mayr et al. CELL
- Distinct Thresholds Govern Myc's Biological Output In Vivo
- (2008) Daniel J. Murphy et al. CANCER CELL
- Differential effects of oncogenic K-Ras and N-Ras on proliferation, differentiation and tumor progression in the colon
- (2008) Kevin M Haigis et al. NATURE GENETICS
- Proliferating Cells Express mRNAs with Shortened 3' Untranslated Regions and Fewer MicroRNA Target Sites
- (2008) R. Sandberg et al. SCIENCE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started